Enliven Therapeutics, Inc. (ELVN) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers the Annual Meeting of Stockholders held by Enliven Therapeutics, Inc. on June 24, 2025. The Company is incorporated in Delaware and its common stock trades on The Nasdaq Global Select Market under the symbol "ELVN". The filing details the voting results for director elections and the ratification of the independent auditor.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and does not contain financial performance data.
Material Changes and Voting Results
The following matters were submitted to a vote of security holders:
- Proposal 1: Election of Three Class II Directors
- Rahul D. Ballal, Ph.D.: Elected with 36,870,420 votes For, 460,073 Withheld, and 8,099,804 Broker Non-Votes.
- Jake Bauer, M.B.A.: Elected with 37,250,826 votes For, 79,667 Withheld, and 8,099,804 Broker Non-Votes.
- Andrew Phillips, Ph.D.: Elected with 31,957,928 votes For, 5,372,565 Withheld, and 8,099,804 Broker Non-Votes.
- All three nominees were duly elected to serve until the 2028 annual meeting.
- Proposal 2: Ratification of Independent Registered Public Accounting Firm
- Stockholders ratified the appointment of Deloitte & Touche LLP for the fiscal year ending December 31, 2025.
- Voting results: 45,392,647 For, 2,435 Against, 35,215 Abstain, and 0 Broker Non-Votes.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to reporting the outcomes of the shareholder vote.
Key Facts for Investor Verification
- Verify the tenure of the newly elected directors (Rahul D. Ballal, Jake Bauer, and Andrew Phillips) through the 2028 annual meeting.
- Confirm the appointment of Deloitte & Touche LLP as the independent auditor for the fiscal year ending December 31, 2025.
- Note the significant number of Broker Non-Votes (8,099,804) recorded for the director elections, indicating shares held in street name where brokers did not have discretionary voting authority.
- Review subsequent filings (e.g., 10-Q or 10-K) for financial performance data, as this 8-K contains no financial metrics.